What is the fair value of 111 Inc (NASDAQ-YI) stock?

The current fair value estimate for 111 Inc (NASDAQ-YI) is $4.88. This implies an estimated upside of 37.3% versus the current market price.

Is 111 Inc (NASDAQ-YI) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 37.3% versus the current market price.

How is the financial health of 111 Inc?

The current financial health read for 111 Inc (NASDAQ-YI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is 111 Inc's next earnings date?

The next earnings date currently listed for 111 Inc (NASDAQ-YI) is November 26, 2026.

Does 111 Inc (NASDAQ-YI) pay dividends?

The latest available data indicates no current dividend yield for 111 Inc (NASDAQ-YI).

What is the market capitalization of 111 Inc?

The current market capitalization listed for 111 Inc is 31.229 M.

What is the enterprise value of 111 Inc?

The current enterprise value listed for 111 Inc is 156.1 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for 111 Inc?

The ticker symbol for 111 Inc is NASDAQ-YI, and the stock is listed on NASDAQ.

Where is 111 Inc (NASDAQ-YI) listed?

111 Inc (NASDAQ-YI) is listed on NASDAQ.

What is the debt-to-total-capital ratio for 111 Inc?

The current debt-to-total-capital ratio listed for 111 Inc is 19.7%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for 111 Inc?

The free float listed for 111 Inc is 52.8%. Free float helps investors understand how much of the share base is available for public trading.

111 Inc (YI) Fair Value & Stock Analysis

111 Inc (YI)

111, Inc. is an American depositary receipt listed on NASDAQ that represents common stock of the underlying issuer. The company, together with its subsidiaries, operates an integrated online and offline healthcare platform in the People's Republic of China. Its business is organized into B2C and B2B segments and includes supply chain integration services, product promotion, customer analytics, patient education, brand awareness support, and marketing and channel data services. Through its online pharmacies, it provides pharmaceutical and health and wellness products, including prescription and over-the-counter medicines, nutritional supplements, contact lenses, medical supplies and devices, and personal care items. The company also offers cloud-based inventory management, smart procurement, online loan application, consultation, e-prescription, and data services, along with warehousing, logistics, research and development, consulting, and IT support. Founded in 2010 and headquartered in Shanghai, it was formerly known as New Peak Group before adopting the 111, Inc. name in 2018.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Next Earnings Date	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Free Cash Flow / Net Income
NASDAQ-YI	$4.88	37.3% Upside	Undervalued	Not available	Not available	Weak	0.0%	November 26, 2026	31.229 M	156.1 M	19.7%	52.8%	-3.7	37.6%